Decreased total and ionized calcium levels and haematological indices in occupational lead exposure as evidence of the endocrine disruptive effect of lead

Indian Journal of Occupational and Environmental Medicine

Volumn 9, Issue 1, 2005, Pages 15-21

  Anetor, J I ^a   Akingbola, T S ^a   Adeniyi, F A A ^a   Taylor, G O I ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

1, 25 dihydroxycholecalciferol; Bloodlead; Endocrine disruptors; Erythropoietin; Haematological indices; Serum calcium

Indexed keywords

CALCIUM; CALCIUM ION; COPPER; HEMOGLOBIN; LEAD; PHOSPHATE; TRACE ELEMENT;

ARTICLE; BLOOD ANALYSIS; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; COMPARATIVE STUDY; CONTROLLED STUDY; COPPER BLOOD LEVEL; DAIRY PRODUCT; DEVELOPING COUNTRY; DIETARY INTAKE; ERYTHROPOIESIS; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY PROXIMAL TUBULE; LEAD POISONING; MAJOR CLINICAL STUDY; MALNUTRITION; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; QUANTITATIVE ANALYSIS; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 18644369308     PISSN: 00195278     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5278.16036     Document Type: Article

References (58)

1. Giwercman A, Skakeback NE. The human testis - an oragn at risk. Int J Androl 1992;15:373-5.
2. Danzo BJ. Environmental xenobiotics may distrucpt normal endocrine function by interfering with the binding of physiological ligands to steroid receptor and binding protein. Environ. Health Perspect 1997;105:294-301.
3. Killington AT. Lead in the working atmosphere and in the environment: Impact of legislation on the use and control of lead within the industry. Chem Indu Str 1983;7:261.
4. Landrigan PJ. Current Issues in the epidemiology and toxicology of occupational exposure to lead. Environ Health Perspect 1990;89:61-6.
5. Goyer RA. Lead toxicity: Current concerns. Ennvironn Health Perspect 1993;100:177-87.
6. NRC (National Research Council) (1993). Measuring lead exposure in infants, children and other sensitive populations. National Research Council, Washington, DC.
7. Hu H, Aro A, Payton M. et al. The relationship of bone and blood lead to hypertension JAMA 1996;275:1171-6.
8. Mahaftey HR. Nutrition and lead: Strategies for Public health. Environm. Health Perspect 1995;103:191-6.
9. Sargent JD. The role of nutrition in the prevention of lead poisoning in children. Pediatr Ann 1995;23:636-42.
10. Goyer RA, Rhyne B. Pathological effects of lead. Int Rev Exp Pathol 1973;12:177.
11. Staessen JA, Lauweys RR, Bulpit CJ, Tondia D, Vanretergehmy, et al. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 327:151-7.
12. Caro J, Ersler AJ. Biologic and immunologic erythropoietin in extracts from hypoxic whole rat kidneys and their glomerular and tubular fractions. J Lab Clin Med 1984;103:922-31.
13. Ersler AJ, Caro J. Physiologic and Molecular biology of erythropoietin. Med Oncol Tumor Pharmcother 1986;3:159-64.
14. Factor-Litvak P, Glaxkovich V, Liu X, Popovac D, Preteni E. et al. Hyperproduction of erythropoietin in nonanemic lead-exposed children. Envrion. Health Perspect 1998;106:361-4.
15. Rosen JF, Chessney RW, Hamstra A, Deluca HF, Mahaftey KR. Reduction in 1, 25-dihydroxyvitamin D in children with increased lead absorption. N Engl J Med 1980;302:1228-31.
16. Aub JC, Fairhall LT, Minot AS, Reznikoff P. Lead poisoning. Medicine 1925;4:1-250.
17. Baker EL, Jr. Landrigan PJ, Barbour AG, Cox DH, Folland DS, Ligo RN, et al. Occupational lead poisoning in the united States: Clinical and Biochemical findings related to blood lead levels. Br J Ind Med 1979;36:314-22.
18. Schwartz J, Landrigan PJ, Baker EL Jr, Orenstein WA, Von-lindern H. Lead-induced anaemia: Dose-response relationships and evidence for a threshold. Am J Public Health 1990;80:169-72.
19. Yamasaki K, Takeyoshi M, Yakabe Y, Sawaki M, Imatanaaka N, Takatsuki M. Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. Toxicology 2002;170:21-30.
20. Takeyoshi M, Yamasaki K, Sawaki M, Makai M, Noda S, Takatsuki M. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions. Toxicology Lett 2002;126:91-8.
21. Pirkle JL, Brody EW, Gunter RA, Kramer DC, Pascal KM, Flegal Matti TP. The decline in blood lead levels in the United States. JAMA 1994;272:284-91.
22. Nriagu JO, Blankson ML, Ockran K. Childhood lead poisoning in Africa: A growing public health problem. Sci Total Envrion 1996;181:93-100.
23. Anetor JI, Adeniyi FAA. Lead poisoning in Africa: A silent epidemic African Scientist 2001;1: 249-56.
24. Anetor JI, Adeniyi FAA, Taylor GOL. Biochemical indicators of metabolic poisoning associated with lead-based occupations in nutritionally disadvantaged communities. Afr J Med Sci 1999;28:9-12.
25. Hessel DW. A simple and rapid quantitative determination of lead in blood. Atom Absorpt Newslett 1968;70:50-5.
26. Baginski ES, Maries ES, Clark WI, Zak B. Calcium in biological fluids. Clinichim. Acta 1973;46:49.
27. Mcleans FL, Hastings AB. The state of calcium in the fluids of the body. J Biol Chem 1935;108:285-322.
28. Beeler MF, Catrou PG. Disorders of calcium metabolism. In: Interpretations in Clinical Chemistry: A Textbook Approach to Chemical Pathology. Chicago: American Society of Clinical Pathologist; 1983. p. 34-44.
29. Fiske CH, Subarrow Y. The colorimetric determination of phosphate.J Biol Chem 1925;66:375-400.
30. Martinek RG. Review of methods for determining, inorganic phosphorus in biological fluids. J Am Med Technol 1970;32:337.
31. Doumas BT, Bayse DD. Carter RJ. A candidate reference method protein in serum. Clin Chem 1981;27:1642.
32. Pinnell AE, Northern BE. New automated dye-binding method for serum albumin determination with bromocresol purple. Clin Chem 1978;24:80.
33. BCSH (British Committee for Standards in Haematology). Standard Haematology Practice. Oxford: Blackwell Scientific Publication; 1991.
34. Varley H, Gowenlock AH, Bell M. Porphyrins, haemoglobins, and related compounds. In: Practical Clinical Biochemistry, Vol. 1, 5th Ed. London: William and Heinemann Medical Books; 1980. p. 960.
35. Vanden Bergh AAH, Snapper J. Farben Stffe des blutserums. Disc Urch Klin Med 1913;110:540-1.
36. Rand RN, Dipasqua A. Determination of serum bilirubin. Clin Chem 1962;8:570.
37. Osheim DC. Atomic absorption determination of copper: A collaborative study. J Assoc Off Anal Chem 1983;66:1140-2.
38. Damstra T. Toxicological properties of lead. Envrion. Health Perspect 1977;19:297-07.
39. Anetor JI. Serum uric acid and standardized urinary protein: Reliable bioindicators of lead nephropathy in Nigerian lead workers. Afr J Biomed Res 2002:5;19-24.
40. Graziano JH, Glavkovich V, Factor-litvak P. Depressed serum erythropoietin in pregnant women with elevated blood lead. Arch Environ Health 1991;46:347-50.
41. Long GJ, Rosen JF, Lead perturbs 1, 25-ditrydroxy vitamin D3 modulation of intracellular calcium metabolism in clonal rat osteoblastic (ROS 17/12.8) Cells Life Sci 1994;54:1395-402.
42. Anetor JI. The probable situation of endocrine disruption in the highly polluted Nigerian environment. (Abstract). In: Scientific Committee on Problems of the environment (SCOPE) / International union of Pare and Applied Chemistry IUPAC International Symposium on Problem on Endocrine Disruptive Substances. Yokohama, Japan: Book of collective abstract and programme; 2002. p. 67-8.
43. Litchman HC, Feldman FC. In vitro pyrrol and porphyrin synthesis in lead poisoning and iron deficiency. J Clin Invest 1963;42:830-9.
44. Piomelli S, Lamola AA, Poh-Fitzpatrick MB, Seaman C, Harber LC. Erythroopoietic protoporphyria and lead intoxication: The molecular basis for difference in cutaneous photosensitivity. 1. Difference rates of disappearance of protoporphyrin from the erythrocytes, both in vivo and vitro. J Clin Invest 1975;56:1519-27.
45. Piomelli S, Seaman C, Zullow D, Curran A, Daviddow B. Threshold for lead damage to heme synthesis in urban children. USA: Proc Natl Acad Sci; 1982;79:3335-9.
46. Brunette MC, Chan M, Ferriere C, Robers K. Site of 1,25(OH)2D3 synthesis in the kidney. Nature 1978;276:287-9.
47. Autor AL. Pathology of oxygen. New York: Academic Press; 1982. p. 361.
48. Monteiro HF, Abdalla DSP, Arcuri AS, Bechara EJC. Oxygen toxicity related to exposure to lead. Clin Chem 1985;31:1673-6.
49. Costa CA, Trivelato GC, Pinto AMP, Biechara EJN. Correlation between Plasma 5-aminolevulinic acid concentrations and indicators of oxidative stress in lead-exposed workers. Clin Chem 1997;43:1196-202.
50. Stocker R, Yamamoto Y, Mendonagen AF. Bilirubin as an antioxidant of possible physiological importance. Science 1987;235:1045-6.
51. Silbergeld EK. Lead in bone: Implications for toxicology during pregnancy and lactation. Environ Health Perspect 1991;9:63-70.
52. Hu H, Watanabe H, Payton M, Korrick S. Rotnitzky A. The relationship between bone lead and haemoglobin. JAMA 1994;272:1512-7.
53. Griggs RC. Lead poisoning: Haematologic aspects. Prog Hematol 1964;4:117-37.
54. Anetor JI. High blood lead levels in the general Nigerian population: Causes and implications. In working paper No.6: Clean Air Initiative in Sub-Saharan African Cities - National Conference on the Phase - out of leaded Gasoline in Nigeria, Abuja, Nigeria, November 15-16 proceedings (November 2001). Wastington DC, USA: The World Bank; 2001. p. 27-37.
55. Staessen JA, Amery A, Benard T, et al. Effect of exposure to cadmium on callium metabolism: A population study. Brit J Ind Med 1991;48:710-4.
56. WHO (World Health Organization). WHO Air quality Guidelines for Europe 2nd Ed. Copenhagen, Denmark: WHO; 2000.
57. Damstra T, Barlow S, Bergman A, Kaylock R, Kraak GVD, editors. Global Assessment of the state-of-the science of Endocrine Disruptors. Geneva, Switzerland: World Health Organisation; 2002.
58. Reutman SR, Lemasters GK, Knetch EA, Shukla R, Lockey JE, Burraughs GE, et al. Evidence of reproductive endocrine effects in women with occupational fuel and solvent exposures. Environ Health Perspect 2002;110:805-11.